A microarray configuration to quantify expression levels and relative abundance of splice variants

Nucleic Acids Research

Volumn 33, Issue 5, 2005, Pages 1-11

  Fehlbaum, Pascale ^a   Guihal, Caroline ^a   Bracco, Laurent ^a   Cochet, Olivier ^a  

^a ExonHit Therapeutics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OLIGONUCLEOTIDE; ISOPROTEIN;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR PROBE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA SPLICING; VALIDATION PROCESS; ALTERNATIVE RNA SPLICING; CELL LINE; CHEMISTRY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; INTRON; METHODOLOGY; VALIDATION STUDY;

ALTERNATIVE SPLICING; CELL LINE; EXONS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTRONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDE PROBES; PROTEIN ISOFORMS;

EID: 26444502673     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gni047     Document Type: Article

References (48)

1. International Human Genome Sequencing Consortium (2004), Finishing the euchromatic sequence of the human genome. [i#Nature#1i], [b#431#1b], 931-945.
2. Lander,E.S. (2001) Initial sequencing and analysis of the human genome. [i#Nature#1i], [b#409#1b], 860-921.
3. Venter,J.C., Adams,M.D., Myers,E.W., Li,P.W., Mural,R.J., Sutton,G.G., Smith,H.O., Yandell,M., Evans,C.A., Holt,RA. [i#et al.#1i] (2001) The sequence of the human genome. [i#Science#1i], [b#291#1b], 1304-1351.
4. Modrek,B. and Lee,C. (2002) A genomic view of alternative splicing. [i#Nature Genet.#1i], [b#30#1b], 13-19.
5. Pospisil,H., Herrmann,A., Bortfeldt,R.H. and Reich,J.G. (2004) EASED: Extended Alternatively Spliced EST Database. [i#Nucleic Acids Res.#1i], [b#32#1b], D70-D74.
6. Thanaraj,T.A., Stamm,S., Clark,F., Riethoven,J.J., Le Texier,V. and Muilu,J. (2004) ASD: The Alternative Splicing Database. [i#Nucleic Acids Res.#1i], [b#32#1b], D64-D69.
7. Huang,Y.H., Chen,Y.T., Lai,J.J., Yang,S.T. and Yang,U.C. (2002) PALS db: Putative Alternative Splicing database. [i#Nucleic Acids Res.#1i], [b#30#1b] 186-190.
8. Rinn,J.L., Euskirchen,G., Bertone,P., Martone,R., Luscombe,N.M., Hartman,S., Harrison,P.M., Nelson,F.K., Miller,P., Gerstein,M. [i#et al.#1i] (2003) The transcriptional activity of human Chromosome 22. [i#Genes Dev.#1i], [b#17#1b], 529-540.
9. Kampa,D., Cheng,J., Kapranov,P., Yamanaka,M., Brubaker,S., Cawley,S., Drenkow,J., Piccolboni,A., Bekiranov,S., Helt,G. [i#et al.#1i] (2004) Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. [i#Genome Res.#1i], [b#14#1b], 331-342.
10. Saha,S., Sparks,A.B., Rago,C., Akmaev,V., Wang,C.J., Vogelstein,B., Kinzler,K.W. and Velculescu,V.E. (2002) Using the transcriptome to annotate the genome. [i#Nat. Biotechnol.#1i], [b#20#1b], 508-512.
11. Faustino,N.A. and Cooper,T.A. (2003) Pre-mRNA splicing and human disease. [i#Genes Dev.#1i], [b#17#1b], 419-437.
12. Garcia-Blanco,M.A., Baraniak,A.P. and Lasda,E.L. (2004) Alternative splicing in disease and therapy. [i#Nat. Biotechnol.#1i], [b#22#1b], 535-546.
13. Stenson,P.D., Ball,E.V., Mort,M., Phillips,A.D., Shiel,J.A., Thomas,N.S., Abeysinghe,S., Krawczak,M. and Cooper,D.N. (2003) Human Gene Mutation Database (HGMD): 2003 update. [i#Hum. Mutat.#1i], [b#21#1b], 577-581.
14. Cartegni,L., Chew,S.L. and Krainer,A.R. (2002) Listening to silence and understanding nonsense: Exonic mutations that affect splicing. [i#Nature Rev. Genet.#1i], [b#3#1b], 285-298.
15. Ladd,A.N. and Cooper,T.A. (2002) Finding signals that regulate alternative splicing in the post-genomic era. [i#Genome Biol.#1i], [b#3#1b] reviews0008.
16. Fairbrother,W.G., Yeh,R.F., Sharp,P.A. and Burge,C.B. (2002) Predictive identification of exonic splicing enhancers in human genes. [i#Science#1i] [b#297#1b], 1007-1013.
17. Stamm,S. (2002) Signals and their transduction pathways regulating alternative splicing: A new dimension of the human genome. [i#Hum. Mol. Genet.#1i], [b#11#1b], 2409-2416.
18. Migliaccio,E., Mele,S., Salcini,A.E., Pelicci,G., Lai,K.M., Superti-Furga,G., Pawson,T., Di Fiore,P.P., Lanfrancone,L. and Pelicci,P.G. (1997) Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. [i#EMBO J.#1i], [b#16#1b], 706-716.
19. Wilson,C.A., Payton,M.N., Elliott,G.S., Buaas,F.W., Cajulis,E:E., Grosshans,D., Ramos,L., Reese,D.M., Slamon,D.J. and Calzone,F.J. (1997) Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. [i#Oncogene#1i], [b#14#1b], 1-16.
20. Wang,J., Gao,Q.S., Wang,Y., Lafyatis,R., Stamm,S. and Andreadis,A. (2004) Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of [i#cis#1i] elements and [i#trans#1i] factors. [i#J. Neurochem.#1i], [b#88#1b], 1078-1090.
21. D'Souza,I. and Schellenberg,G.D. (2000) Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. [i#J. Biol. Chem.#1i], [b#275#1b], 17700-17709.
22. Umeda,Y., Taniguchi,S., Arima,K., Piao,Y.S., Takahashi,H., Iwatsubo,T., Mann,D. and Hasegawa,M. (2004) Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies. [i#Neurosci. Lett.#1i], [b#359#1b], 151-154.
23. de Silva,R., Lashley,T., Gibb,G., Hanger,D., Hope,A., Reid,A., Bandopadhyay,R., Utton,M., Strand,C., Jowett,T. [i#et al.#1i] (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. [i#Neuropathol. Appl. Neurobiol.#1i], [b#29#1b], 288-302.
24. Kalbfuss,B., Mabon,S.A. and Misteli,T. (2001) Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17. [i#J. Biol. Chem.#1i], [b#276#1b], 42986-42993.
25. Feldkotter,M., Schwarzer,V., Wirth,R., Wienker,T.F. and Wirth,B. (2002) Quantitative analyses of SMN1 and SMN2 based on real-time light Cycler PCR: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. [i#Am. J. Hum. Genet.#1i], [b#70#1b], 358-368.
26. Harada,Y., Sutomo,R., Sadewa,A.H., Akutsu,T., Takeshima,Y., Wada,H., Matsuo,M. and Nishio,H. (2002) Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: Three SMN2 copies fail to rescue some patients from the disease severity. [i#J. Neurol.#1i], [b#249#1b] 1211-1219.
27. Cartegni,L. and Krainer,A.R. (2003) Correction of disease-associated exon skipping by synthetic exon-specific activators. [i#Nature Struct. Biol.#1i], [b#10#1b], 120-125.
28. Sumner,C.J., Huynh,T.N., Markowitz,J.A., Perhac,J.S., Hill,B., Coovert,D.D., Schussler,K., Chen,X., Jarecki,J., Burghes,A.H. [i#et al.#1i] (2003) Valproic acid increases SMN levels in spinal muscular atrophy patient cells. [i#Ann. Neurol.#1i], [b#54#1b], 647-654.
29. Skordis,L.A., Dunckley,M.G., Yue,B., Eperon,I.C. and Muntoni,F. (2003) Bifunctional antisense oligonucleotides provide a [i#trans#1i]-acting splicing enhancer that stimulates [i#SMN2#1i] gene expression in patient fibroblasts. [i#Proc. Natl Acad. Sci. USA#1i], [b#100#1b], 4114-4119.
30. Brichta,L., Hofmann,Y., Hahnen,E., Siebzehnrubl,F.A., Raschke,H., Blumcke,I., Eyupoglu,I.Y. and Wirth,B. (2003) Valproic acid increases the SMN2 protein level: A well-known drug as a potential therapy for spinal muscular atrophy. [i#Hum. Mol. Genet.#1i], [b#12#1b], 2481-2489.
31. Wirth,B. (2002) Spinal muscular atrophy: State-of-the-art and therapeutic perspectives. [i#Amyotroph. Lateral Scler. Other Motor Neuron Disord.#1i], [b#3#1b], 87-95.
32. Darreh-Shori,T., Hellstrom-Lindahl,E., Flores-Flores,C., Guan,Z.Z., Soreq,H. and Nordberg,A. (2004) Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. [i#J. Neurochem.#1i], [b#88#1b], 1102-1113.
33. Vandenbroucke,I.I., Vandesompele,J., Paepe,A.D. and Messiaen,L. (2001) Quantification of splice variants using real-time PCR. [i#Nucleic Acids Res.#1i], [b#29#1b], E68.
34. Perez,C., Vandesompele,J., Vandenbroucke,I., Holtappels,G., Speleman,F., Gevaert,P., Van Cauwenberge,P. and Bachert,C. (2003) Quantitative real time polymerase chain reaction for measurement of human interleukin-5 receptor alpha spliced isoforms mRNA. [i#BMC Biotechnol.#1i], [b#3#1b], 17.
35. Veistinen,E., Liippo,J. and Lassila,O. (2002) Quantification of human Aiolos splice variants by real-time PCR. [i#J. Immunol. Methods#1i], [b#271#1b], 113-123.
36. Shulzhenko,N., Smirnova,A.S., Morgun,A. and Gerbase-DeLima,M. (2003) Specificity of alternative splice form detection using RT-PCR with a primer spanning the exon junction. [i#Biotechniques#1i], [b#34#1b], 1244-1249.
37. Wagner,E.J., Curtis,M.L., Robson,N.D., Baraniak,A.P., Eis,P.S. and Garcia-Blanco,M.A. (2003) Quantification of alternatively spliced FGFR2 RNAs using the RNA invasive cleavage assay. [i#RNA#1i], [b#9#1b], 1552-1561.
38. Yeakley,J.M., Fan,J.B., Doucet,D., Luo,L., Wickham,E., Ye,Z., Chee,M.S. and Fu,X.D. (2002) Profiling alternative splicing on fiber-optic arrays. [i#Nat. Biotechnol.#1i], [b#20#1b], 353-358.
39. Hu,G.K, Madore,S.J., Moldover,B., Jatkoe,T, Balaban,D., Thomas,J. and Wang,Y. (2001) Predicting splice variant from DNA chip expression data. [i#Genome Res.#1i], [b#11#1b], 1237-1245.
40. Clark,T.A., Sugnet,C.W. and Ares,M.,Jr (2002) Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. [i#Science#1i] [b#296#1b], 907-910.
41. Wang,H., Hubbell,E., Hu,J.S., Mei,G., Cline,M., Lu,G., Clark,T., Siani-Rose,M.A., Ares,M., Kulp,D.C. [i#et al.#1i] (2003) Gene structure-based splice variant deconvolution using a microarry platform. [i#Bioinformatics#1i], [b#19#1b] (Suppl 1), I315-I322.
42. Johnson,J.M., Castle,J., Garrett-Engele,P., Kan,Z., Loerch,P.M., Armour,C.D., Santos,R., Schadt,E.E., Stoughton,R. and Shoemaker,D.D. (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. [i#Science#1i], [b#302#1b], 2141-2144.
43. Castle,J., Garrett-Engele,P., Armour,C.D., Duenwald,S.J., Loerch,P.M., Meyer,M.R., Schadt,E.E., Stoughton,R., Parrish,M.L., Shoemaker,D.D. [i#et al.#1i] (2003) Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing. [i#Genome Biol.#1i], [b#4#1b], 19.
44. Connelly,M.A., Zhang,H., Kieleczawa,J. and Anderson,C.W. (1996) Alternate splice-site utilization in the gene for the catalytic subunit of the DNA-activated protein kinase, DNA-PKcs. [i#Gene#1i], [b#175#1b], 271-273.
45. Bergsdorf C., Paliga,K., Kreger,S., Masters,C.L. and Beyreuther,K. (2000) Identification of [i#cis#1i]-elements regulating exon 15 splicing of the amyloid precursor protein pre-mRNA. [i#J. Biol. Chem.#1i], [b#275#1b] 2046-2056.
46. Shoemaker,D.D., Schadt,E.E., Armour,C.D., He,Y.D., Garrett-Engele,P., McDonagh,P.D., Loerch,P.M., Leonardson,A., Lum,P.Y., Cavet,G. [i#et al.#1i] (2001) Experimental annotation of the human genome using microarray technology. [i#Nature#1i], [b#409#1b], 922-927.
47. Kapranov,P., Cawley,S.E., Drenkow,J., Bekiranov,S., Strausberg,R.L., Fodor,S.P. and Gingeras,T.R. (2002) Large-scale transcriptional activity in chromosomes 21 and 22. [i#Science#1i], [b#296#1b], 916-919.
48. Hiller,M., Huse,K., Szafranski,K, Jahn,N., Hampe,J., Schreiber,S., Backofen,R. and Platzer,M. (2004) Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity. [i#Nature Genet.#1i], [b#36#1b], 1255-1257.